GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Symbol: APLT
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$149,330	1,492,903	+214,747	+17%	$0.10	Q4 2025
30 Sep 2025	0%	+0%	$773,417	1,278,156	+309,615	+32%	$0.61	Q3 2025
30 Jun 2025	0%	-0%	$301,436	968,541	-1,182,851	-55%	$0.31	Q2 2025
31 Mar 2025	0%	+0%	$1,052,052	2,151,392	+67,250		$0.49	Q1 2025
31 Dec 2024	0%	0%	$1,784,854	2,084,142	-7,527	-0.36%	$0.86	Q4 2024
30 Sep 2024	0%	-0%	$17,782,490	2,091,669	-7,146	-0.34%	$8.50	Q3 2024
30 Jun 2024	0%	+0%	$9,802,702	2,098,815	+1,494,387	+247%	$4.67	Q2 2024
31 Mar 2024	0%	+0%	$4,111,335	604,428	+26,757	+4.6%	$6.80	Q1 2024
31 Dec 2023	0%	+0%	$1,935,527	577,671	+134,199	+30%	$3.35	Q4 2023
30 Sep 2023	0%	+0%	$1,104,515	443,472	+2,967	+0.67%	$2.49	Q3 2023
30 Jun 2023	0%	+0%	$563,846	440,505	+79,427	+22%	$1.28	Q2 2023
31 Mar 2023	0%	0%	$292,870	361,078	0		$0.81	Q1 2023
31 Dec 2022	0%	+0%	$274,000	361,078	+29,012	+8.7%	$0.76	Q4 2022
30 Sep 2022	0%	+0%	$308,000	332,066	+169,623	+104%	$0.93	Q3 2022
30 Jun 2022	0%	-0%	$154,000	162,443	-125,487	-44%	$0.95	Q2 2022
31 Mar 2022	0%	-0%	$607,000	287,930	-15,313	-5%	$2.11	Q1 2022
31 Dec 2021	0%	-0%	$2,714,000	303,243	-12,851	-4.1%	$8.95	Q4 2021
30 Sep 2021	0%	+0%	$5,247,000	316,094	+25,174	+8.7%	$16.60	Q3 2021
30 Jun 2021	0%	+0%	$6,045,000	290,920	+34,953	+14%	$20.78	Q2 2021
31 Mar 2021	0%	+0%	$4,800,000	255,967	+66,479	+35%	$18.75	Q1 2021
31 Dec 2020	0%	+0%	$4,170,000	189,488	+19,660	+12%	$22.01	Q4 2020
30 Sep 2020	0%	+0%	$3,525,000	169,828	+3,908	+2.4%	$20.76	Q3 2020
30 Jun 2020	0%	+0%	$5,998,000	165,920	+39,224	+31%	$36.15	Q2 2020
31 Mar 2020	0%	+0%	$4,141,000	126,696	+58,946	+87%	$32.68	Q1 2020
31 Dec 2019	0%	+0%	$1,848,000	67,750	+43,634	+181%	$27.28	Q4 2019
30 Sep 2019	0%	+0%	$265,000	24,116	+24,116	NEW	$10.99	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.